Axoltis Pharma
PrivateLast Round
Series A
Dec 2, 2025
Est. Valuation
$37.63M
Total Funding Raised
$23.32M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Axoltis Pharma is a biotechnology company that develops innovative drugs for neurodegenerative and neurotraumatic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axoltis Pharma Comparables
Compare Axoltis Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AL-S Pharma AG | 81% | |
| Primary Peptides, Inc. | 80% | |
| Revalesio | 79% | |
Axoltis Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 2, 2025 | ||||
| Seed | Jun 15, 2016 |
Key People
Founding team and executive leadership
Axoltis Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ODDO BHF Group | Series A |
| UI Investissement | Seed |
| Angelor | Seed, Series A |
| Norfoalk | Series A |
| Sofimac Investment Managers | Seed, Series A |
| Capital Cell | Series A |
| UI Investissement | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 7, 47% of headcount.
- Jul 24, 2026
Monthly visitors increased 6587% MoM, from 30 to 2K.
Axoltis Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axoltis Pharma's valuation, stock price, and market status.